| YGL214W |
Saccharomyces cerevisiae |
|
YGL214W is differentially expressed in 4 experiments [6 up/7 dn]: 2 compound treatments: doxycycline [1 up/0 dn], none [0 up/1 dn], 2 developmental stages: mitotic growth [0 up/1 dn], meiotic development [1 up/0 dn], 3 genotypes, 5 growth conditions, 1 temperatures |
| YGL214W |
|
|
| integral to membrane |
|
|
|
P53087
|
|
|
|
YGL214W
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Doxycycline
|
Compound treatment |
|
|
None
|
Compound treatment |
|
|
Dessication
|
Growth condition |
|
|
Abf1-1 hypomorph / GAL-ABF1 ov...
|
Genotype |
|
|
YPA media
|
Growth condition |
|
|
TetO2-PAF1-6HA
|
Genotype |
|
|
Control
|
Growth condition |
|
|
GAL-ABF1 overexpression transg...
|
Genotype |
|
|
37 degree_C
|
Temperature |
|
|
Mitotic growth
|
Developmental stage |
|
|
Meiotic development
|
Developmental stage |
|
|
Rehydration
|
Growth condition |
|
|
50% dessication
|
Growth condition |
|
|
|
|
|
Processing time: 0.023 secs.